PACGEN LIFE SCIENCE CORPORATION ("PBS")
BULLETIN TYPE: Plan of Arrangement-, Delist
BULLETIN DATE: September 30, 2020
TSX Venture Tier 2 Company
Pursuant to special resolutions passed by the shareholders of PACGEN LIFE SCIENCE CORPORATION ("Pacgen") on September 15, 2020, Pacgen and General Biologicals Corporation ("GBC") have completed a plan of arrangement under Section 288 of the Business Corporations Act (British Columbia). The Plan of Arrangement has been completed on Sept 30, 2020, and has resulted in all issued and outstanding common shares of Pacgen ("Common Shares"), other than Common Shares held by GBC, its Executive Chairman and affiliated companies (the "Continuing Shareholders"), being acquired by GBC at an acquisition price of $0.0275 per Common Share (the "Acquisition Price").
Effective at the close of business, Thursday Oct 1, 2020, the common shares will be delisted from TSX Venture Exchange.
Further information on the arrangement is available on the Company's SEDAR profile in the Information Circular dated August 17, 2020 and in a news release dated July 7, 2020 & Sept 30, 2020.
________________________________________
|
|
